Patient Tolerability Study of GSK163090

Clinical trial NCT00559299 · COMPLETED

Trial details

NCT number: NCT00559299
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder, Major Major Depressive Disorder (MDD)

Start date: 2007-11-01
Primary completion: 2008-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.